Synopsys Inc. 8-K/A Report: Key Update on Board Committee Appointment

Here are the key insights extracted from the provided section of the financial report for Synopsys Inc. (SEC CIK: 0000883241):

1. Document Type and Filing:

• This is an Amendment to a current report filed on Form 8-K/A.
• The original report was filed on July 17, 2025.

2. Company Information:

• Name: Synopsys, Inc.
• Address: 675 Almanor Ave, Sunnyvale, CA 94085
• Phone: (650) 584-5000
• Stock Information: Common Stock with a par value of $0.01 per share, traded on NASDAQ under the ticker symbol "SNPS".

3. Amendment Purpose:

• The sole purpose of this amendment is to provide additional information regarding Mr. Vijayaraghavan’s appointment to a committee of Synopsys’ Board of Directors.
• The section being updated falls under "Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers".

4. Key Dates:

• Amendment Date: July 17, 2025.
• The reporting period covers the same date, indicating a same-day filing.

5. No Additional Changes:

• The amendment does not include any other changes to the original 8-K report beyond the update on Mr. Vijayaraghavan’s committee appointment.

This information highlights the focus of the report on board governance, particularly changes in committee assignments, which can be significant for stakeholders monitoring corporate governance and executive decisions at Synopsys.